Large Cap / Pharmaceuticals, Biotechnology & Life Sciences
BMY Commences Tender Offer to Purchase All Outstanding Shares of AMLN

Bristol-Myers Squibb Began Tender Offer to Acquire Amylin Pharmaceuticals, Inc.

July 10, 2012

On July 10, 2012, Bristol-Myers Squibb Company (NYSE: BMY) commenced a cash tender offer to purchase all outstanding shares of common stock of Amylin Pharmaceuticals, Inc.

To view the full article, please subscribe or login.

Profit from The Turnaround Letter's...

  • Market-Beating Investment Results
  • 27+ Years of Turnaround Experience
  • Diverse Stock Picks for Today's Unpredictable Market

Distressed Investing Blog

Distressed Investing Blog

Buy & Hold: The Turnaround Letter's Time-Tested Investing Strategy

Since publishing our first issue back in 1986, we’ve always recommended investors exercise patience. "Beware an Itchy Trigger Finger" identified ten stock picks with particularly promising long-term potential--and they all had the added bonus of paying dividends over 3% to further reward investor patience. Given our contrarian slant, each of these stocks was also generally out of favor with mainstream investors at the time of recommendation--adding value stock appeal. Read More.

Free Stock Report

 

Put George Putnam's 27+ years of market-beating, contrarian investing advice to work for you, and give your portfolio a boost with this FREE stock report.

Current Total Returns

 

Value Stock Profit

Total returns cover the fulll year 2013.

Note: Returns are not adjusted for inflation.

 

Read More.

Sample Issue

TL Spotlight

 

Value Stock Picks

 

MoneyShow.com named George's stock pick top performer for all of 2013 and shared this feature interview to update investors on MTG's status and highlight select year-end bounce candidates.

 

Learn more.